Expression of E-cadherin and PCNA in pancreatic adenocarcinoma and their clinic significance

Jun Zhao,Jianfeng Yao,Jiancang Ma,Guanghui Zhao,Liang Luo

DOI: https://doi.org/10.3969/j.issn.1671-8259.2006.03.018

2006-01-01

Abstract:Objective: To study the expression of E-cadherin and PCNA in pancreatic adenocarcinoma and their clinical significance. Methods: E-cadherin and PCNA in 59 cases of pancreatic adenocarcinoma was studied by immunohistochemistry. Results: The decreased expression of E-cadherin in pancreatic adenocarcinoma was significantly lower than that in normal pancreas; the higher rate of expression only was 13.6% (8/59); and the expression of E-cadherin in various groups was statistically significant with the differentiation of carcinoma; the metastasis of lymph nodes and the clinical stages (P<0.05); the increased expression of PCNA in pancreatic adenocarcinoma was significantly higher than that in normal pancreas; the higher positive rate of PCNA was 67.8% (40/59); and the expression of PCNA in various groups was significant in statistics with the differentiation of carcinoma; the metastasis of lymph nodes and the clinical stages(P<0.05); the correlation between E-cadherin and PCNA was negative in pancreatic adenocarcinoma. (P<0.05). Conclusion: The abnormal expression of E-cadherin and PCNA are closely associated with the differentiation, proliferation, invasion and metastasis of nancreatic adenocarcinoma.